Faculty profile

Jeff Chen

Back to faculty

Associate Professor - Affiliated InstituteDepartment of Medical BiophysicsWestern University

Jeff Chen

Associate Professor - Affiliated Institute

Department of Medical Biophysics

Schulich School of Medicine & Dentistry

Western University

London, Ontario, Canada

Supervision signals

Professors usually supervise graduate students in their department's programs.
4 publications in the last five years, latest in 2025.
Supervisor on 1 trainee award (1 CIHR), most recently in 2016.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

University Profile Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their Western University profile.

Latest papers

Radiation vs. trans-oral surgery for treatment de-escalation in HPV-related oropharyngeal cancers: Primary analysis of the ORATOR2 randomized trial.
European journal of cancer (Oxford, England : 1990) · 2025
Radiotherapy Versus Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma: Final Results of the ORATOR Randomized Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2024
Assessment of Toxic Effects and Survival in Treatment Deescalation With Radiotherapy vs Transoral Surgery for HPV-Associated Oropharyngeal Squamous Cell Carcinoma: The ORATOR2 Phase 2 Randomized Clinical Trial.
JAMA oncology · 2022

All 38 publications

Latest funding

Development of Unified Intensity-Modulated Arc Therapy
CIHR · 2016 · Supervisor
$105,000
Fast Dose Optimization of the Radiation Treatment of Cancer
NSERC · 2004 · Co-investigator
$125,000

All 2 grants and awards

38 publications.

Radiation vs. trans-oral surgery for treatment de-escalation in HPV-related oropharyngeal cancers: Primary analysis of the ORATOR2 randomized trial.

Palma DA, Prisman E, Berthelet E, Tran E, Hamilton S, Wu J, Eskander A, Higgins K, Karam I, Poon I, Husain Z, Enepekides D, Hier M, Richardson K, Mlynarek A, Johnson-Obaseki S, Gaudet M, Bayley A, Dowthwaite S, Jackson JE, Dzienis M, O'Neil J, Chandarana S, Banerjee R, Hart R, Chung J, Tenenholtz T, Le H, Yoo J, Mendez A, Winquist E, Kuruvilla S, Stewart P, Warner A, Mitchell S, Chen J, Parker C, Kwan K, Theurer J, Bahig H, Christopoulos A, Mendez LC, Sathya J, Hammond JA, Read N, Venkatesan V, Fung K, Nichols AC

European journal of cancer (Oxford, England : 1990)2025

DOI: 10.1016/j.ejca.2025.115343 PMID: 40121836

Radiotherapy Versus Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma: Final Results of the ORATOR Randomized Trial.

Nichols AC, Theurer J, Prisman E, Read N, Berthelet E, Tran E, Fung K, de Almeida JR, Bayley A, Goldstein DP, Hier M, Sultanem K, Richardson K, Mlynarek A, Krishnan S, Le H, Yoo J, MacNeil SD, Winquist E, Hammond JA, Venkatesan V, Kuruvilla S, Warner A, Mitchell S, Chen J, Johnson-Obaseki S, Odell M, Corsten M, Parker C, Wehrli B, Kwan K, Palma DA

Journal of clinical oncology : official journal of the American Society of Clinical Oncology2024

DOI: 10.1200/jco.24.00119 PMID: 39303189

Assessment of Toxic Effects and Survival in Treatment Deescalation With Radiotherapy vs Transoral Surgery for HPV-Associated Oropharyngeal Squamous Cell Carcinoma: The ORATOR2 Phase 2 Randomized Clinical Trial.

Palma DA, Prisman E, Berthelet E, Tran E, Hamilton S, Wu J, Eskander A, Higgins K, Karam I, Poon I, Husain Z, Enepekides D, Hier M, Sultanem K, Richardson K, Mlynarek A, Johnson-Obaseki S, Odell M, Bayley A, Dowthwaite S, Jackson JE, Dzienis M, O'Neil J, Chandarana S, Banerjee R, Hart R, Chung J, Tenenholtz T, Krishnan S, Le H, Yoo J, Mendez A, Winquist E, Kuruvilla S, Stewart P, Warner A, Mitchell S, Chen J, Parker C, Wehrli B, Kwan K, Theurer J, Sathya J, Hammond JA, Read N, Venkatesan V, MacNeil SD, Fung K, Nichols AC

JAMA oncology2022

DOI: 10.1001/jamaoncol.2022.0615 PMID: 35482348

Randomized Trial of Radiotherapy Versus Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma: Long-Term Results of the ORATOR Trial.

Nichols AC, Theurer J, Prisman E, Read N, Berthelet E, Tran E, Fung K, de Almeida JR, Bayley A, Goldstein DP, Hier M, Sultanem K, Richardson K, Mlynarek A, Krishnan S, Le H, Yoo J, MacNeil SD, Winquist E, Hammond JA, Venkatesan V, Kuruvilla S, Warner A, Mitchell S, Chen J, Corsten M, Johnson-Obaseki S, Odell M, Parker C, Wehrli B, Kwan K, Palma DA

Journal of clinical oncology : official journal of the American Society of Clinical Oncology2022

DOI: 10.1200/jco.21.01961 PMID: 34995124

Alert system for monitoring changes in patient anatomy during radiation therapy of head and neck cancer.

Schaly B, Kempe J, Venkatesan V, Mitchell S, Chen J

Journal of applied clinical medical physics2021Senior author

DOI: 10.1002/acm2.13342 PMID: 34302421

Is hypofractionated whole pelvis radiotherapy (WPRT) as well tolerated as conventionally fractionated WPRT in prostate cancer patients? The HOPE trial.

Mendez LC, Arifin AJ, Bauman GS, Velker VM, Ahmad B, Lock M, Venkatesan VM, Sexton TL, Rodrigues GB, Chen J, Schaly B, Warner A, D'Souza DP

BMC cancer2020

DOI: 10.1186/s12885-020-07490-0 PMID: 33036579

A Phase I/II Trial of Fairly Brief Androgen Suppression and Stereotactic Radiation Therapy for High-Risk Prostate Cancer (FASTR-2): Preliminary Results and Toxicity Analysis.

Callan L, Bauman G, Chen J, Lock M, Sexton T, D'Souza D, Rodrigues G

Advances in radiation oncology2019

DOI: 10.1016/j.adro.2019.07.007 PMID: 31681864

Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trial.

Nichols AC, Theurer J, Prisman E, Read N, Berthelet E, Tran E, Fung K, de Almeida JR, Bayley A, Goldstein DP, Hier M, Sultanem K, Richardson K, Mlynarek A, Krishnan S, Le H, Yoo J, MacNeil SD, Winquist E, Hammond JA, Venkatesan V, Kuruvilla S, Warner A, Mitchell S, Chen J, Corsten M, Johnson-Obaseki S, Eapen L, Odell M, Parker C, Wehrli B, Kwan K, Palma DA

The Lancet. Oncology2019

DOI: 10.1016/s1470-2045(19)30410-3 PMID: 31416685

A generalized parametric response mapping method for analysis of multi-parametric imaging: A feasibility study with application to glioblastoma.

Lausch A, Yeung TP, Chen J, Law E, Wang Y, Urbini B, Donelli F, Manco L, Fainardi E, Lee TY, Wong E

Medical physics2017

DOI: 10.1002/mp.12562 PMID: 28875538

Extreme hypofractionation for high-risk prostate cancer: Dosimetric correlations with rectal bleeding.

Bauman G, Chen J, Rodrigues G, Davidson M, Warner A, Loblaw A

Practical radiation oncology2017

DOI: 10.1016/j.prro.2017.06.002 PMID: 28734642

Profile data last refreshed on November 9, 2025 from the university directory, publication records and CIHR, NSERC and SSHRC funding.

Something wrong or missing on this profile? Suggest a correction

Jeff Chen

Research

Latest papers

Latest funding

Radiation vs. trans-oral surgery for treatment de-escalation in HPV-related oropharyngeal cancers: Primary analysis of the ORATOR2 randomized trial.

Radiotherapy Versus Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma: Final Results of the ORATOR Randomized Trial.

Assessment of Toxic Effects and Survival in Treatment Deescalation With Radiotherapy vs Transoral Surgery for HPV-Associated Oropharyngeal Squamous Cell Carcinoma: The ORATOR2 Phase 2 Randomized Clinical Trial.

Randomized Trial of Radiotherapy Versus Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma: Long-Term Results of the ORATOR Trial.

Alert system for monitoring changes in patient anatomy during radiation therapy of head and neck cancer.

Is hypofractionated whole pelvis radiotherapy (WPRT) as well tolerated as conventionally fractionated WPRT in prostate cancer patients? The HOPE trial.

A Phase I/II Trial of Fairly Brief Androgen Suppression and Stereotactic Radiation Therapy for High-Risk Prostate Cancer (FASTR-2): Preliminary Results and Toxicity Analysis.

Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trial.

A generalized parametric response mapping method for analysis of multi-parametric imaging: A feasibility study with application to glioblastoma.

Extreme hypofractionation for high-risk prostate cancer: Dosimetric correlations with rectal bleeding.

Development of Unified Intensity-Modulated Arc Therapy

Fast Dose Optimization of the Radiation Treatment of Cancer

Frequent collaborators

Glenn Bauman

George Rodrigues

Keith Kwan

Julie Theurer

Eric Winquist

Bret Wehrli

Eitan Prisman

Ting-Yim Lee

Stewart Gaede

Edward Yu

Andrew Loblaw

Bryan Schaly

Robert Hart

Antoine Eskander

Danny Enepekides

Jerry Battista

Scott Karnas

Craig Lewis

Marc Gaudet

Maria Drangova

Aaron Fenster

Libni Eapen